Enhabit (EHAB) Matches Q4 Earnings Estimates

Impact · against what's priced in

Enhabit's Q4 results are marginally positive but lack a significant catalyst, as the small earnings and revenue beats are likely already reflected in the stock's strong year-to-date performance.

SERA+0.10

No priced-in read yet

In context

The company beat earnings estimates by 3.70% ($0.14 vs $0.13) and revenue estimates by 0.40% ($270.4 million), showing steady year-over-year growth in both metrics.

Read from the article alone

• healthcare▲20%
• earnings▲2%
• revenue
• SERA
• eps
• home health
• hospice
• medical services